Director, Chief Executive Officer · LIFECORE BIOMEDICAL, INC. \DE\ · Common Stock
Side
F
Value
$185K
Shares
40.4K
Price
$4.57
Executed
May 20, 2026
Disclosed
May 21, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
May 20 executedMay 21, 2026 disclosed
LFCR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+8 / 25
$185K reported value · 7.3% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Josephs Paul filed this Form 4 reporting a tax withholding of LFCR on May 20, 2026. It became public on May 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Josephs Paulcik:0002022547
Issuer
LIFECORE BIOMEDICAL, INC. \DE\cik:0001005286
Revision history · 0
No field has changed since this record was first ingested.
